Sanoev Zafar Isomiddinovich
Sanoev Zafar Isomiddinovich
PhD, associates professor
Information:
Laboratory
Department of Pharmacology and Toxicology
Degree
PhD, associates professor
Contact:
Phone
+998909924086
International Scientific Bases:
Social Networks:

Sanoev Zafar Isomiddinovich

PhD, associates professor

List of Articles

# FULL TITLE LINK
1 Z.I. Sanoev, T.T. Khamroev, I.T. Abdinazarov, S.D. Rakhimboev, S.Z. Rashidov, D.S. Ismailova, B.Zh. Elmuradov. EVALUATION OF THE EFFECT OF EPITRIAZOLINE ON THE GENERAL BLOOD COUNT, BIOCHEMICAL AND MACROSCOPIC CONDITION OF THE INTERNAL ORGANS OF EXPERIMENTAL ANIMALS WITH PROLONGED ADMINISTRATION. 2026
OAK (Republic)
View
2 Zafar Isomiddinovich Sanoev, Sokhib Zamon Ogli Rashidov, Tolmas Tolibovich Khamroev, Ibrokhimjon Tuychievich Abdinazarov, Sukhrob Davlatyor Ogli Rakhimboev, Dilnoza Safaralievna Ismailova , Burkhon Zhuraevich Elmuradov and Madina Aladdin kizi Shakhmurova. Synthesis and Antidepressant Activity of 5-(2-Aminophenyl)-1,3,4-Oxadiazole-2-(3H)-Thione. 2026
Scopus
View
3 Sultanov S. A., Sanoyev Z. I., Sirov V. N., Ismailova D. S., Elmuradov B. J.. Pharmacological and Toxicological Evaluation of 5-(p-Aminophenyl)-1,3,4-oxadiazole-2-thione Potassium Salt: Acute Toxicity and Anxiolytic Activity in Experimental Models. 2026
OAK (international)
View
4 . Rahimboyev, S., Sanoev, Z., Hamroyev, T., Abdinazarov, I., Rashidov, S., Ismoilova, D., & Elmuradov, B.. 5-(p-aminofenil)-4-amino-1,2,4-triazol-3(2H)-tionning o‘tkir zaharliligi va tutqanoqqa qarshi faolligi. 2025
OAK (Republic)
View
5 Rahimboev S. D., Sanoev Z. I., Khamroyev T. T., Abdinazarov I. T., Rashidov S. Z., Ismoilova D. S., & Elmuradov B.. Safety assessment of the 4- (6-phenyl-7H - [1,2,4] triazolo [3,4-b] [1,3,4] thiadiazine-3-yl) -aniline compound and the effects of the substance on respiration and cardiac activity. 2025
OAK (international)
View
6 Salokhiddinova Rushana Kamoliddinkhon kizi Saidaliyeva Ziyodabegim Jamshid kizi Shamshimedov Mukhammadjon Bakhtiyor ugli, Sanoev Zafar Isomidinovich. ROLE OF DOPAMINERGIC MEDIATORS IN THE DEVELOPMENT OF SCHIZOPHRENIA (Literature Review). 2025
OAK (Republic)
View